Aquestive Therapeutics Announces U.S. FDA Filing Acceptance of New Drug Application for Clobazam Oral Soluble Film to Treat Lennox-Gastaut Syndrome

January 18, 2018

Responsive image

WARREN, N.J., Jan. 18, 2018 /PRNewswire/ — Aquestive Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application for clobazam Oral Soluble Film (clobazam OSF) for adjunctive treatment of seizures…

Category: Precious Metals